Vol. 7, Issue 2, Part B (2025)

Benign prostatic hyperplasia (BPH) remains a prevalent urological condition in aging males, frequently necessitating surgical intervention when medical management fails. Transurethral resection of the prostate (TURP) is now regarded as the "gold standard" for the surgical management of symptomatic BPH since it removes the intravesical obstruction and improves voiding parameters and symptoms. The principal of this endoscopic surgery and some of the subsequent consequences, such as the high rate of postoperative recurrence, remain unchanged, despite the advancements made in TURP surgical equipment, necessitating a significant innovation in the surgical technique. One potential alternate treatment for BPH is bipolar transurethral enucleation of the prostate (B-TUEP). In conjunction with a bipolar resection sheath, this procedure calls for the utilization of a modified B-TUEP electrode and the conventional bipolar electrosurgical device. The goal of this procedure is to increase the advantages of bipolar electrocautery and the superiority of enucleation over resection. B-TUEP has been shown to produce superior urinary functional outcomes in recent comparative trials and observational studies, as evidenced by significant improvements in maximal urinary flow rates, international prostate symptom scores (IPSS), and reductions in post-void residual volumes. These benefits can be attributed to the whole anatomical resection of adenoma in enucleation, which more closely approximates open prostatectomy while minimizing invasiveness. Both techniques are associated with the risk of postoperative sexual dysfunction, particularly retrograde ejaculation. However, B-TUEP may have a slightly higher incidence as a result of the more extensive resection in the near ejaculatory ducts.